COMMUNICATION
Phosphoinositide 3-Kinase gamma  Is a Mediator of Gbeta gamma -dependent Jun Kinase Activation*

Marco Lopez-Ilasaca, J. Silvio GutkindDagger , and Reinhard Wetzker§

From the Max Planck Research Unit "Molecular Cell Biology," Medical Faculty, University of Jena, 07747 Jena, Germany and the Dagger  Molecular Signaling Unit, Laboratory of Cellular Development and Oncology, NIDR, National Institutes of Health, Bethesda, Maryland 20892

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Jun kinases (JNK) are involved in the stress response of mammalian cells. Stimulation of JNK can be induced by stress factors and by agonists of tyrosine kinase and G protein-coupled receptors. G protein-dependent receptors stimulate JNK via Gbeta gamma subunits of heterotrimeric G proteins, but the subsequent signaling reaction has been undefined. Here we demonstrate JNK activation in COS-7 cells by Gbeta gamma -stimulated phosphoinositide 3-kinase gamma  (PI3Kgamma ). Signal transduction from PI3Kgamma to JNK can be suppressed by dominant negative mutants of Ras, Rac, and the protein kinase PAK. These results identify PI3Kgamma as a mediator of Gbeta gamma -dependent regulation of JNK activity.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Interaction of cells with a wide variety of agonists results in a stimulation of intracellular mitogen-activated protein kinase (MAPK)1 cascades. MAPKs control the expression of genes that are important for the regulation of many cell functions including proliferation and differentiation. In mammalian cells three parallel MAPK pathways have been characterized so far (1). The canonical MAPK cascade composed of Raf, MEK, and ERK is regulated by the Ras GTPase in response to agonists of tyrosine kinase and G protein-coupled receptors. ERK species catalyze the phosphorylation of transcription factors including Elk-1, thus controlling the expression of several genes (2).

A second MAPK cascade that is stimulated by osmotic stress regulates the activity of the protein kinase p38. Signal transduction to p38 and the function of this pathway are still unclear. Like p38 the elements of the Jun kinase (JNK) cascade as a third MAPK pathway are involved in the stress response of mammalian cells. JNK can be stimulated by stress factors like interleukin 1 and tumor necrosis factor but also by agonists of tyrosine kinase and G protein-coupled receptors (3, 4). Available evidences point to an involvement of the small GTPase Rac and several protein kinases in the regulation of JNK activity (5). In some cellular systems the STE 20 homologue PAK was found to act as a JNK kinase kinase kinase (6). PAK is able to activate JNK via sequential stimulation of the protein kinases MEKK and SEK.

The mechanism of signal transduction from G protein-coupled receptors to the JNK cascade is only partially understood. Using COS-7 cells as a transient expression system a recent report showed the involvement of Gbeta gamma subunits of heterotrimeric G proteins in the stimulation of JNK by agonists of the G protein-coupled muscarinergic receptor m2 (7). Additionally the small GTPases Ras and Rac have been demonstrated to mediate signal transduction from G protein-coupled receptor to JNK, but the topology of the signaling path from Gbeta gamma to Ras and Rac remains unknown (7-9).

One candidate for the link of G protein-coupled receptor and JNK cascade is phosphoinositide 3-kinase gamma  (PI3Kgamma ). This subspecies of the PI3K family is stimulated in vitro by Gbeta gamma and recently has been shown to be involved in signal transduction from G protein-coupled receptor to the ERK path of MAPK cascades (10). We now present evidences that JNK stimulation by an agonist of the m2 muscarinergic receptor and by Gbeta gamma also implies a PI3K. Overexpression of PI3Kgamma in COS-7 cells induces a significant increase of JNK activity. Stimulation of JNK by Gbeta gamma can be suppressed by the PI3K inhibitor wortmannin and a lipid kinase negative mutant of PI3K. Dominant negative mutants of Ras, Rac, and PAK significantly reduce the stimulatory effect of PI3Kgamma on JNK. Thus PI3Kgamma seems to act as an intermediate connecting G protein-coupled receptors to the JNK cascade.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Cell Culture and Transfection-- COS-7 cells (ATCC) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Cells were split the day before transfection. Subconfluent cells were transfected with pcDNAIII-HA-JNK or pcDNAIII-HA-MAPK and additional DNAs, following the DEAE-dextran technique, adjusting the total amount of DNA to 5 µg per plate with vector DNA when necessary. Assays were performed 48 h after transfection (9). For JNK assays the cells were serum-starved for 2 h, whereas for MAPK the cells were starved overnight in serum-free medium.

DNA Constructs-- Expression plasmids for an epitope-tagged JNK and MAPK, pcDNA3 HA-JNK and pcDNA3 MAPK, respectively, as well as expression plasmids for the dominant negative mutants of the small GTP-binding proteins Ras, RhoA, Rac1, and Cdc42 have been described (9, 11). PI3Kgamma and dominant negative PI3Kgamma were used as described previously (10). pcDNA3-p101 was kindly provided by Dr. Len Stephens and prepared as published recently (12). An expression plasmid for the N-terminal 150-amino acid noncatalytic domain of Pak1, which contains the Rac/Cdc42 binding region, was cloned into pcDNA3 vector coding the NH2-terminal myristoylation membrane localization signal from c-Src (13, 14). The final construct was designated pcDNA3-myr-PAK(N). Efficacy of dominant negative mutants of PI3Kgamma , Ras, RhoA, Rac1, Cdc42, and PAK to suppress muscarinergic response in COS-7 cells has been established recently (7, 10, 14).

Kinase Assays-- JNK assays in cells transfected with an epitope-tagged JNK construct (HA-JNK) was determined as described previously (9) using purified, bacterially expressed GST-ATF2(96) fusion protein as a substrate. Briefly, serum-starved cells left untreated or stimulated with various agents were lysed, and after centrifugation, clarified supernatants were immunoprecipitated with an anti-hemagglutinin monoclonal antibody 12CA5 (Babco, Richmond, CA) for 1-2 h at 4 °C, and immunocomplexes were recovered with the aid of GammaBind (Pharmacia, Uppsala). Pellets were then washed three times with phosphate-buffered saline solution, supplemented with 1% Nonidet P-40, and 2 mM sodium vanadate, once with 0.5 M LiCl in 100 mM Tris, pH 7.5, and once with kinase reaction buffer (12.5 mM MOPS, pH 7.5, 12.5 mM beta -glycerophosphate, 7.5 mM MgCl2, 0.5 mM EGTA, 0.5 mM sodium fluoride, 0.5 mM vanadate). Reactions were performed in a 30-µl volume of kinase reaction buffer containing 1 µCi of [gamma -32P]ATP/reaction, 20 µM unlabeled ATP, and 1.5 mg/ml substrate at 30 °C for 30 min. Reactions were terminated by addition of 5× Laemmli buffer, boiled, and electrophoresed in 12% polyacrylamide gel. Phosphorylated GST-ATF2(96) was visualized by autoradiography and quantified with a PhosphorImager. MAPK activity in cells transfected with an epitope-tagged MAPK (HA-MAPK) was determined as described previously (11). In each case, parallel samples were immunoprecipitated with anti-HA antibody and processed by Western blot analysis using the appropriate antibody (Santa Cruz Technology, Santa Cruz, CA). Immunocomplexes were visualized by enhanced chemiluminescence detection (Amersham) with the use of goat antiserum to rabbit or mouse immunoglobulin G coupled to horseradish peroxidase (Santa Cruz Technology).

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

To investigate signaling from G protein-coupled receptor to JNK the muscarinergic m2 receptor has been transiently expressed in COS-7 cells. Confirming previous results (7) we observed an increase of JNK activity after treatment with the receptor agonist carbachol (Fig. 1A). Overexpression of Gbeta gamma mimics the effect of carbachol on JNK. As shown in Fig. 1A both m2- and Gbeta gamma -mediated stimulation could be effectively suppressed by wortmannin, a specific inhibitor of PI3K. In contrast JNK activation by the stress-inducing agent anisomycin was unaffected by wortmannin, demonstrating the specificity of this approach. Another PI3K inhibitor LY 294002 decreased JNK stimulation induced by Gbeta gamma in a dose-dependent manner (Fig. 1B). Together these data point to an involvement of PI3K in the stimulation of JNK by G protein-coupled receptor.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 1.   Inhibition of JNK activation in COS-7 cells by wortmannin and LY 294002. A, effect of wortmannin on the stimulation of JNK induced by the m2 muscarinergic receptor and 1 mM carbachol (m2), Gbeta gamma , or anisomycin. Two days after transfection with expression plasmids of HA-JNK, and as indicated m2 receptor or Gbeta gamma cells were treated for 15 min with carbachol or anisomycin (10 µg/ml) in the presence or absence of 100 nM wortmannin. After lysis of the cells JNK kinase activity was assayed as described under "Experimental Procedures." B, dose-response effect of the PI3K inhibitor LY294002 on JNK stimulation induced by Gbeta gamma and anisomycin.

Trying to outline the PI3K species that induces Gbeta gamma -dependent JNK activation we expressed PI3Kgamma in COS-7 cells. As shown in Fig. 2A, PI3Kgamma moderately stimulated JNK activity. This effect could be significantly enhanced by coexpression of p101, a PI3Kgamma -binding protein recently discovered (12). p101 alone was unable to induce JNK stimulation. For a comparison Fig. 2A expresses the individual effects of p101, PI3Kgamma , and PI3Kgamma  + p101 on MAP kinase (ERK) activity. Interestingly p101 exhibited significantly lower potency to affect PI3Kgamma -dependent MAPK activity than JNK induced by PI3Kgamma . To examine possible autocrine reactions of the transfectants we analyzed the effects of conditioned media from COS-7 cells expressing PI3Kgamma and/or p101 on naive cells. Supernatants of the transfected cells did not induce any measurable stimulation of JNK activity in untreated cells, thus providing evidence for direct signaling from PI3Kgamma and p101 to JNK (data not shown). Fig. 2B demonstrates the dependence of JNK activation on the expression levels of p101 and PI3Kgamma . Thus optimal stimulation of JNK seems to depend on PI3Kgamma and p101.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   JNK activation by PI3Kgamma in COS-7 cells. A, stimulation of JNK and MAPK activities by expression of PI3Kgamma and/or p101. COS-7 cells were transfected with HA-JNK or HA-MAPK and as indicated control vector or the expression plasmids of PI3Kgamma and/or p101. After 2 days cells were lysed, and JNK or MAPK activity was assayed. B, dose-response effect of PI3Kgamma and p101 on JNK activity. COS-7 cells were transfected with the control vector or indicated amounts of expression plasmids of PI3Kgamma and p101, and JNK activity was assayed after 2 days.

The activatory effect of PI3Kgamma on JNK could be completely inhibited by wortmannin suggesting an important role of the kinase activities of the PI3K (Fig. 3A). PI3Kgamma recently has been shown to exhibit a significant ability to catalyze autophosphorylation in addition to its lipid kinase activity (15). Both kinase activities depend on magnesium and can be inhibited by nanomolar concentrations of wortmannin. A recently described mutant of PI3Kgamma K799R, which does not express significant lipid kinase and protein kinase activities, was able to suppress the JNK stimulation induced by Gbeta gamma (Fig. 3B). Together with our previous report (10) these findings provide clear evidence that PI3Kgamma links both JNK and MAPK to G protein-coupled receptors. Involvement of PI3Kalpha , which recently has been shown to mediate signaling of platelet-derived growth factor receptor tyrosine kinase to JNK (16) seems improbable.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 3.   Requirement of PI3Kgamma catalytic activity for JNK activation. A, wortmannin blocks JNK activation induced by PI3Kgamma . COS-7 cells transfected with control vector or the expression plasmid of PI3Kgamma were treated with the indicated concentrations of wortmannin, and JNK activity was assayed. B, suppression of Gbeta gamma -mediated JNK activation by dominant negative mutant PI3Kgamma K799R. Pure vector or expression plasmids of Gbeta gamma or RacQL and as indicated the dominant negative mutant PI3Kgamma K799R were used for transfection. JNK activity was assayed after 48 h.

The recently described involvement of Ras and Rac in signal transduction from G protein-coupled receptors to JNK prompted us to investigate a possible role of these small GTPases in JNK stimulation induced by PI3Kgamma . As shown in Fig. 4A coexpression of dominant negative forms of Ras and Rac prevented activation of JNK by PI3Kgamma . In contrast coexpression of the negative mutants of two other small GTPases RhoA and Cdc42 did not affect the stimulation of JNK by PI3Kgamma . Therefore Ras and Rac1 seem to represent essential elements of the signaling path from PI3Kgamma to JNK. Expression of beta ARK as a binding protein for Gbeta gamma (9, 10) also suppressed JNK stimulation induced by PI3Kgamma (data not shown). This effect points to an essential role of Gbeta gamma as a link of G protein-coupled receptors to PI3Kgamma .


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 4.   Involvement of Ras, Rac, and PAK in JNK activation by PI3Kgamma . A, effects of dominant negative mutants of Ras, Rac1, Cdc42, and RhoA on JNK activation induced by PI3Kgamma and p101. COS-7 cells were transfected with control vector or expression plasmids of PI3Kgamma and p101 and with dominant negative mutants of Ras, Rac1, Cdc42, and RhoA, and JNK was assayed after 2 days. B, effect of dominant negative PAK on JNK activation by PI3Kgamma . Stimulation of JNK was induced by expression of Gbeta gamma , PI3Kgamma  + p101, RacQL or incubation with anisomycin (10 µg/ml, 15 min), and the effect of dominant negative PAK(N) expression on JNK activity was assayed. Levels of JNK expression were equal in every assay (data not shown).

We next explored a possible involvement of protein kinase PAK in downstream signaling from PI3Kgamma to JNK. The coexpression of a dominant negative mutant of this protein kinase also induced a partial suppression of JNK stimulation by Gbeta gamma , PI3Kgamma , and a constitutively active mutant of Rac (Fig. 4B). Thus signaling from G protein-coupled receptor to JNK appears to require Gbeta gamma , PI3Kgamma , Ras, Rac, and PAK.

Nevertheless the sequence of events connecting PI3Kgamma and JNK remains unclear. A PI3Kgamma effect on Ras has been proposed in our previous report on ERK activation by PI3Kgamma (10). In this paper we provide evidences that Ras could be activated by PI3Kgamma via a Src-type tyrosine kinase, the adapter proteins Shc and Grb2, and the guanine nucleotide exchange factor Sos. Stimulated in this way Ras could act as a dissociation point for signals from PI3Kgamma to ERK and JNK. Such a bifurcating function of Ras as a regulator of the Raf-ERK path and signal transduction to Rac, PAK, and JNK has been proposed (6).

Despite the attractiveness of this model some experimental data point to a more complex relation of the signaling proteins involved. Thus the differential effects of p101 on the PI3Kgamma -dependent stimulation of ERK and JNK cannot be explained by simple sequential signal transduction from PI3Kgamma via the lipid kinase product PIP3 to Ras and subsequent stimulation of JNK and ERK paths. One possible explanation for the distinct effects of PI3Kgamma and its ligands on the MAPK cascades could be the involvement of signaling activities of the enzyme in addition to PIP3 production. Wortmannin-sensitive protein kinase activity of PI3Kgamma has been reported (15). If Gbeta gamma and p101 produce divergent effects on the lipid kinase and protein kinase activities of PI3Kgamma and if both activities are important for signal transduction different downstream events could be expected. The individual signaling functions of PI3Kgamma lipid kinase and protein kinase activities are currently under investigation. The effects of PI3Kgamma on different MAPK cascades clearly represent another example for the complex interrelations of these intracellular signaling proteins.

    ACKNOWLEDGEMENTS

We are very grateful to Drs. Len Stephens and Phill Hawkins for providing us with the pcDNA3-p101 construct.

    FOOTNOTES

* This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 197.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Max-Planck Research Unit "Molecular Cell Biology," Drackendorfer Straße 1, D 07747 Jena, Germany. Tel.: 49-3641-304-460; Fax: 49-3641-304-462; E-mail: i5rewe{at}rz.uni-jena.de.

1 The abbreviations used are: MAPK, mitogen-activated protein kinase; PI3K, phosphoinositide 3-kinase; ERK, extracellular signal-regulated kinase; JNK (or SAPK), c-Jun NH2-terminal kinase (or stress-activated protein kinase); PIP3, phosphatidylinositol 3,4,5-trisphosphate; HA, hemagglutinin; MOPS, 4-morpholinepropanesulfonic acid.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

  1. Cano, E., and Mahadevan, L. C. (1995) Trends Biochem. Sci. 20, 117-122[CrossRef][Medline] [Order article via Infotrieve]
  2. Davis, R. J. (1993) J. Biol. Chem. 270, 14553-14556
  3. Kyriakis, J., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E., Ahmad, M., Avruch, J., and Woodgett, J. (1994) Nature 369, 156-160[CrossRef][Medline] [Order article via Infotrieve]
  4. Coso, O. A., Chiariello, M., Kalinec, G., Kyriakis, J. M., Woodgett, J., Gutkind, J. S. (1995) J. Biol. Chem. 270, 5620-5624[Abstract/Free Full Text]
  5. Ridley, A. J. (1996) Curr. Biol. 6, 1256-1264[Medline] [Order article via Infotrieve]
  6. Bagrodia, S., Derijard, B., Davis, R. J., Cerione, R. A. (1995) J. Biol. Chem. 270, 27995-27998[Abstract/Free Full Text]
  7. Coso, O. A., Teramoto, H., Simonds, W. F., Gutkind, J. S. (1996) J. Biol. Chem. 271, 3963-3966[Abstract/Free Full Text]
  8. Minden, A., Lin, A., Claret, F.-X., Abo, A., and Karin, M. (1995) Cell 81, 1147-1157[Medline] [Order article via Infotrieve]
  9. Coso, O. A., Chiariello, M., Yu, J.-C., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. (1995) Cell 81, 1137-1146[Medline] [Order article via Infotrieve]
  10. Lopez-Ilasaca, M., Crespo, P., Pellici, P. G., Gutkind, S., Wetzker, R. (1997) Science 275, 394-397[Abstract/Free Full Text]
  11. Crespo, P., Xu, N., Simonds, W. F., Gutkind, J. S. (1994) Nature 369, 418-420[CrossRef][Medline] [Order article via Infotrieve]
  12. Stephens, L. R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A. S., Thelen, M., Cadwallader, K., Tempst, P., Hawkins, P. T. (1997) Cell 89, 105-114[Medline] [Order article via Infotrieve]
  13. Takeya, T., and Hanafusa, H. (1983) Cell 32, 881-889[Medline] [Order article via Infotrieve]
  14. Teramoto, H., Crespo, P., Coso, O. A., Igishi, T., Xu, N., Gutkind, J. S. (1996) J. Biol. Chem. 271, 25731-25734[Abstract/Free Full Text]
  15. Stoyanova, S., Bulgarelli-Leva, G., Kirsch, C., Hanck, T., Klinger, R., Wetzker, R., and Wymann, M. P. (1997) Biochem. J. 324, 489-495[Medline] [Order article via Infotrieve]
  16. Lopez-Ilasaca, M., Li, W., Uren, A., Yu, J., Kazlauskas, A., Gutkind, J. S., Heidaran, M. A. (1997) Biochem. Biophys. Res. Commun. 232, 273-277[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.